Bottom line
Is GBATX a good fund? The bottom line
GBATX is an actively managed allocation / balanced mutual fund from Gmo.
Annual fees run 0.91% — about $91 a year on every $10,000 invested, more expensive than 51% of allocation / balanced funds we track.
It returned +24.8% over one year, +9.0% a year over five years, +8.4% a year over ten (as of Dec 31, 2025, per its prospectus).
With $74.5 million in net assets and 19 holdings, its largest position is GMO Alternative Allocation Fund (18.1%) and the top 10 make up 89% of the portfolio.
What stands out
- 5-year return beat 91% of category peers
What to watch
- Concentrated: top 10 holdings are 89% of assets
Updated Nov 19, 2026
What GBATX invests in
Total return greater than that of its benchmark, the GMO Strategic Opportunities Allocation Index, an internally maintained composite index computed by GMO, consisting of 75% MSCI World Index (MSCI Standard Index Series) and 25% Bloomberg U.S. Aggregate Index.
The investment strategies GMO pursues for the Fund are intended to complement the strategies it is pursuing for other accounts it manages. Accordingly, the Fund is not intended to serve as a standalone investment. The Fund invests in direct investments, shares of other series of GMO Trust whether now existing or created in the future, including the Equity Funds, the Fixed Income Funds, the Implementation Funds and the Alternative Funds, and shares of GMO-managed exchange-traded funds (collectively, the underlying GMO Funds) (see Additional Information About the Funds Investment Strategies, Risks, and Expenses Asset Allocation Funds). GMO uses its quantitative multi-year forecasts of returns among asset classes, together with its assessment of the relative risks of asset classes, to determine the asset classes in which the Fund invests and how much the Fund invests in each asset class.…
From the fund's prospectus (filed Oct 20, 2026).
GBATX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| GBATX | +24.8% | +9.0% | +8.4% |
| Allocation / Balanced median | +11.0% | +5.7% | +6.7% |
Source: Fund prospectus, as of Dec 31, 2025
What GBATX costs
On a $10,000 investment, GBATX's 0.91% expense ratio costs about $91 a year. The prospectus estimates $1,249 in total costs over 10 years (assuming 5% annual returns). The median allocation / balanced fund charges 0.91%.
GBATX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | GMO Alternative Allocation Fund | 18.07% |
| 2 | GMO International Equity Fund | 17.76% |
| 3 | GMO Asset Allocation Bond Fund | 8.99% |
| 4 | GMO International Opportunistic Value Fund | 8.00% |
| 5 | GMO US Opportunistic Value Fund | 7.97% |
| 6 | GMO US Equity Fund | 7.29% |
| 7 | GMO-Usonian Japan Value Creation Fund | 7.28% |
| 8 | GMO Emerging Markets Fund | 7.21% |
| 9 | GMO Quality Fund | 3.58% |
| 10 | GMO US Treasury Fund | 2.85% |
Source: SEC Form N-PORT, period ended May 31, 2026
The top 10 make up 89% of the fund. See all top 25 holdings and asset mix →